KRAS and non-small cell lung carcinoma: This patient had KRAS-mutated metastatic adenocarcinoma NSCLC, enrolled in June 2019 after three previous lines of treatment, and remained relapse free without any subsequent treatment 5 years after the last vaccination (Figure 6D).